On window mean survival time with interval-censored data

Takuto Iijima, Tomotaka Momozaki, Shuji Ando

In recent years, cancer clinical trials have increasingly encountered non proportional hazards (NPH) scenarios, particularly with the emergence of immunotherapy. In randomized cont…